Download PDF
Thromb Haemost 2007; 98(02): 479-481
DOI: 10.1160/TH06-12-0696
Letters to the Editor
Schattauer GmbH

Plasminogen activator inhibitor-1 has a circadian rhythm in blind individuals

John A. Schoenhard
1   Vanderbilt University Medical Center, Nashville, Tennessee, USA
,
James A. S. Muldowney III
1   Vanderbilt University Medical Center, Nashville, Tennessee, USA
,
Jonathan S. Emens
2   Oregon Health Sciences University, Portland, Oregon, USA
,
Alfred J. Lewy
2   Oregon Health Sciences University, Portland, Oregon, USA
,
Douglas E. Vaughan
1   Vanderbilt University Medical Center, Nashville, Tennessee, USA
› Author Affiliations Financial support: This work was supported by National Institutes of Health grants HL65192 and HL81009 to D.E.V., MH56874 to A.J.L., and GM07347 to the Vanderbilt University Medical Scientist Training Program. J.A.S.M. was supported by the Stanley J. Sarnoff Endowment for Cardiovascular Research.
Further Information

Publication History

Received 06 December 2006

Accepted after resubmission 15 May 2007

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Cohen MC, Rohtla KM, Lavery CE. et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79: 1512-1516.
    CrossrefPubMedGoogle Scholar
  • 2 Elliot WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998; 29: 992-996.
    CrossrefPubMedGoogle Scholar
  • 3 Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79: 101-106.
    CrossrefPubMedGoogle Scholar
  • 4 Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995; 91: 1341-1346.
    CrossrefPubMedGoogle Scholar
  • 5 Katz RJ, Hsia J, Walker P. et al. Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors. Am J Cardiol 1996; 78: 876-880.
    CrossrefPubMedGoogle Scholar
  • 6 Bridges AB, McLaren M, Scott NA. et al. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 1993; 69: 121-124.
    CrossrefPubMedGoogle Scholar
  • 7 Huber K, Rosc D, Resch I. et al. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstablecoronary artery disease and acute myocardial infarction. Thromb Haemost 1988; 60: 372-376.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Masuda T, Ogawa H, Miyao Y. et al. Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J 1994; 71: 156-161.
    CrossrefPubMedGoogle Scholar
  • 9 Akiyama Y, Kazama M, Tahara C. et al. Reference values of hemostasis related factors of healthy Japaneses adults I: Circadian fluctuation. Thromb Res 1990; 60: 281-289.
    CrossrefPubMedGoogle Scholar
  • 10 Johansen LG, Gram J, Kluft C. et al. Chronobiology of coronary risk markers in Greenland Eskimos: a comparative study with Caucasians residing in the same Arctic area. Chronobiol Int 1991; 8: 352-360.
    CrossrefPubMedGoogle Scholar
  • 11 Maemura K, dela Monte SM, Chin MT. et al. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem 2000; 275: 36847-36851.
    CrossrefPubMedGoogle Scholar
  • 12 Schoenhard JA, Smith LH, Painter CA. et al. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol 2003; 35: 473-481.
    CrossrefPubMedGoogle Scholar
  • 13 Minami Y, Horikawa K, Akiyama M. et al. Restricted feeding induces daily expression of clock genes and PAI-1 mRNA in theheart of Clock mutant mice. FEBS Letters 2002; 526: 115-118.
    CrossrefPubMedGoogle Scholar
  • 14 Ohkura N, Oishi K, Fukushima N. et al. Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression. J Thromb Haemost 2006; 4: 2478-2485.
    CrossrefPubMedGoogle Scholar
  • 15 Kudo T, Nakayama E, Suzuki S. et al. Cholesterol diet enhances daily rhythm of PAI-1 mRNA in the mouse liver. Am J Physiol Endocrinol Metab 2004; 287: E644-651.
    CrossrefPubMedGoogle Scholar
  • 16 Kudo T, Akiyama M, Kuriyama K. et al. Night-time restricted feeding normalises clock genes and PAI-1 gene expression in the db/db mouseliver. Diabetologia 2004; 47: 1425-1436.
    PubMedGoogle Scholar
  • 17 Naito Y, Tsujino T, Kawasaki D. et al. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 2003; 21: 1107-1115.
    CrossrefPubMedGoogle Scholar
  • 18 Tsujino T, Naito Y, Kawasaki D. et al. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Clin Exp Hypertens 2005; 27: 159-168.
    CrossrefPubMedGoogle Scholar
  • 19 Oishi K, Ohkura N, Kasamatsu M. et al. Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes. Thromb Res 2004; 114: 129-135.
    CrossrefPubMedGoogle Scholar
  • 20 Oishi K, Ohkura N, Wakabayashi M. et al. CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J Thromb Haemost 2006; 4: 1774-1780.
    CrossrefPubMedGoogle Scholar
  • 21 Brown NJ, Agirbasli MA, Williams GH. et al. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32: 965-971.
    CrossrefPubMedGoogle Scholar
  • 22 Irokawa M, Nishinaga M, Funayama H. et al. Effect of a change in the sleep/wake cycle on the diurnal variation of fibrinolytic parameters. J Thromb Thrombolysis 1998; 5: 165-168.
    CrossrefPubMedGoogle Scholar
  • 23 Sack RL, Brandes RW, Kendall AR. et al. Entrainment of free-running circadian rhythmsby melatonin in blind people. N Engl J Med 2000; 343: 1070-1077.
    CrossrefPubMedGoogle Scholar
  • 24 Lewy AJ, Emens JS, Bernert RA. et al. Eventual entrainment of the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implications. J Biol Rhythms 2004; 19: 68-75.
    CrossrefPubMedGoogle Scholar
  • 25 Lewy AJ, Emens JS, Sack RL. et al. Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int 2002; 19: 649-658.
    CrossrefPubMedGoogle Scholar
  • 26 Emens JS, Lewy AJ, Lefler BJ. et al. Relative coordination of unknown “weak zeitgebers”in free-running blind individuals. J Biol Rhythms 2005; 20: 159-167.
    CrossrefPubMedGoogle Scholar
  • 27 Lewy AJ, Bauer VK, Hasler BP. et al. Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res 2001; 918: 96-100.
    CrossrefPubMedGoogle Scholar
  • 28 Fisher NI, Lee AJ. A correlation coefficient for circular data. Biometrika 1983; 70: 327-332.
    CrossrefPubMedGoogle Scholar